Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Crosby
Gerard Crosby, South Hurstville AU
| Patent application number | Description | Published |
|---|---|---|
| 20100173693 | GAMING MACHINE WITH RANDOM DISPLAY FIELD SYMBOL POPULATION - A gaming machine including a display for display of symbols; said machine causing said symbols to be displayed in an array of fields; said array of fields in the form of substantially vertically aligned fields and substantially horizontally aligned fields; said symbols selected from a pool of n symbols for populating said array of fields according to the following steps: | 07-08-2010 |
Ian Crosby, Hawthorn AU
| Patent application number | Description | Published |
|---|---|---|
| 20090170926 | Antiviral agents - The present invention provides a method of treatment or prophylaxis of hepatitis B virus in a subject comprising administering an effective amount of a compound of formula ( | 07-02-2009 |
James Arthur Crosby, Rosarito Beach MX
| Patent application number | Description | Published |
|---|---|---|
| 20100184344 | PERSONAL FLOTATION DEVICE - This invention describes a buoyancy aid that is pre-formed from a buoyant foam plastic material and has an pre-formed internal tube that is sealed. The internal tube and the pre-formed buoyant foam are all shaped to provide support for a users head, and is designed to keep the users head above water. The buoyancy aid has an external covering that is selected to prevent chafing the user, as well as being water and mold resistant. The buoyancy aid is so designed as to be comfortable to the user, and enhance the wearers use of the buoyancy aid. | 07-22-2010 |
Javier Crosby, Santiago CL
| Patent application number | Description | Published |
|---|---|---|
| 20110244464 | IDENTIFICATION OF GENES OR POLYPEPTIDES THE EXPRESSION OF WHICH CORRELATES TO FERTILITY, OVARIAN FUNCTION AND/OR FETAL/NEWBORN VIABILITY - A genetic means of determining whether a female subject produces “pregnancy competent” oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the “pregnancy signature”, also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. Microarrays containing “pregnancy signature” genes or corresponding polypeptides provide another preferred aspect of the invention. Still further, the subject invention can be used to derive animal models, e.g., non-human primate animal models, for the evaluation of the efficacy of putative female fertility treatments. | 10-06-2011 |
Peter Andrew Crosby, New South Wales AU
| Patent application number | Description | Published |
|---|---|---|
| 20100036487 | Blood Pump With An Ultrasound Transducer - A blood pump including a ultrasonic sensor mounted in or on a blood contacting surface of said blood pump. The ultrasonic sensor measures blood velocity and reports information to a blood pump controller and wherein the ultrasonic sensor is directed to measure blood velocity in an inflow cannula connected to the blood pump. | 02-11-2010 |
Peter Andrew Crosby, Manly AU
| Patent application number | Description | Published |
|---|---|---|
| 20080221921 | METHOD OF CONDUCTING A CLINICAL TRIAL - Disclosed are methods of conducting and assessing the outcomes of a randomized controlled clinical trial. The method comprises the steps of: trialing, with respect to a first group of patients as an experimental group, an experimental treatment; and trialing, with respect to a second group of patients as a control group, at least first and second control therapies. The control therapies will have been previously validated or are a known standard of care. This method is described in relation to trialing and assessing implantable medical devices such as left ventricular assist devices (LVAD) but may be used for trialing and assessing other medical devices. | 09-11-2008 |